In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific.  Some ideas the two discussed during their conversation include:The significance of personalized medicine, and how marrying proteomics with genomics can better support individual health journeys.How precision medicine could change the relationship between the clinical lab and physicians.Ways Thermo Fisher’s Orbitrap Astral Mass Spectrometer supports lab clinicians.Current challenges and predictions in the space.